CRSPCRISPR Therapeutics AG

$59.27

What is the market doing?

What the tape says about CRSP

CRISPR Therapeutics AG is +5.9% over the past year while the S&P 500 is +23%: 17 points behind the market.

+5.9%

1-year return · S&P 500 +23%

vs 200-day average
+11%

vs 200-day average · a clear uptrend

RSI (14)
67

RSI (14) · neutral

Below its 52-week high
−23%

Below its 52-week high

2024-08-06$31.27 – $76.78 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$59.27
1 monthS&P 500 +3.7%
+25%
1 yearS&P 500 +23%
+5.9%
5 yearsS&P 500 +87%
−52%
vs 50-day average$52.55
+13%
52-week high
$76.78
52-week low
$44.34
Annualised volatility
60%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$3.4M
Calendar-year price return
YearReturn
2026 (year to date)+13%
2025+33%
2024−37%
2023+54%
2022−46%
2021−51%
2020+151%
2019+113%
2018+22%
2017+16%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan106 of 10+7.3%
Feb107 of 10+9.8%
Mar102 of 10−11%
Apr107 of 10+0.56%
May106 of 10+8.7%
Jun107 of 10+11%
Jul107 of 10+2.4%
Aug105 of 10+1.4%
Sep92 of 9−5.8%
Oct93 of 9−4.5%
Nov107 of 10+17%
Dec102 of 10−6.5%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.